140 related articles for article (PubMed ID: 2942467)
1. Detection of brain autoantibodies in the serum of patients with Alzheimer's disease but not Down's syndrome.
Singh VK; Fudenberg HH
Immunol Lett; 1986 Jun; 12(5-6):277-80. PubMed ID: 2942467
[TBL] [Abstract][Full Text] [Related]
2. Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome.
Singh VK; Fudenberg HH
Autoimmunity; 1989; 3(2):95-101. PubMed ID: 2535254
[TBL] [Abstract][Full Text] [Related]
3. Immunologic dysfunction: simultaneous study of Alzheimer's and older Down's patients.
Singh VK; Fudenberg HH; Brown FR
Mech Ageing Dev; 1986-1987 Jan; 37(3):257-64. PubMed ID: 2952844
[TBL] [Abstract][Full Text] [Related]
4. Detection of anti-cerebral autoantibodies in schizophrenia and Alzheimer's disease.
Sugiura M; Yokoi Y; Maruyama S; Ishido T; Tokunaga Y; Sasaki K
J Clin Lab Immunol; 1989 Jan; 28(1):1-3. PubMed ID: 2657070
[TBL] [Abstract][Full Text] [Related]
5. Neuron-binding antibodies in Alzheimer's disease and Down's syndrome.
Franceschi M; Comola M; Nemni R; Pinto P; Iannaccone S; Smirne S; Canal N
J Gerontol; 1989 Jul; 44(4):M128-30. PubMed ID: 2525583
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease and Down's syndrome antibodies bind to the heavy neurofilament protein of cholinergic neurons.
Tchernakov K; Soussan L; Hassin-Baer S; Wertman E; Michaelson DM
Res Immunol; 1992; 143(6):670-5. PubMed ID: 1455060
[No Abstract] [Full Text] [Related]
7. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
8. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes in sera from patients with Alzheimer's disease, multi-infarct dementia and Down's syndrome.
Heinonen O; Syrjänen S; Soininen H; Talasniemi S; Kaski M; Mäntyjärvi R; Syrjänen K; Riekkinen P
Neurosci Lett; 1993 Jan; 149(1):67-70. PubMed ID: 8469384
[TBL] [Abstract][Full Text] [Related]
10. Antibodies from Down's syndrome patients bind to the same cholinergic neurofilament protein recognized by Alzheimer's disease antibodies.
Hassin-Baer S; Wertman E; Raphael M; Stark V; Chapman J; Michaelson DM
Neurology; 1992 Mar; 42(3 Pt 1):551-5. PubMed ID: 1532232
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte capping in Down's syndrome and Alzheimer's disease.
Brohée D
J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):370. PubMed ID: 2951500
[No Abstract] [Full Text] [Related]
12. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders.
Smith TW; Lippa CF
J Neuropathol Exp Neurol; 1995 May; 54(3):297-303. PubMed ID: 7745428
[TBL] [Abstract][Full Text] [Related]
13. Anti-acetylcholine receptor antibody in aged individuals and in patients with Down's syndrome.
Tanaka M; Miyatake T
J Neuroimmunol; 1983 Feb; 4(1):17-24. PubMed ID: 6218184
[TBL] [Abstract][Full Text] [Related]
14. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown.
Levin EC; Acharya NK; Han M; Zavareh SB; Sedeyn JC; Venkataraman V; Nagele RG
Brain Res; 2010 Jul; 1345():221-32. PubMed ID: 20546711
[TBL] [Abstract][Full Text] [Related]
15. Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type.
Fillit HM; Kemeny E; Luine V; Weksler ME; Zabriskie JB
J Gerontol; 1987 Mar; 42(2):180-4. PubMed ID: 2950160
[TBL] [Abstract][Full Text] [Related]
16. The role of Th17 cells in auto-inflammatory neurological disorders.
Tahmasebinia F; Pourgholaminejad A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):408-416. PubMed ID: 28760387
[TBL] [Abstract][Full Text] [Related]
17. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
[TBL] [Abstract][Full Text] [Related]
18. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
Blusztajn JK; Lopez Gonzalez-Coviella I; Logue M; Growdon JH; Wurtman RJ
Brain Res; 1990 Dec; 536(1-2):240-4. PubMed ID: 2150771
[TBL] [Abstract][Full Text] [Related]
19. Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients.
Singh VK; Yang YY; Singh EA
Neurosci Lett; 1992 Nov; 147(1):25-8. PubMed ID: 1282691
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease in Down's syndrome. A review.
Karlinsky H
J Am Geriatr Soc; 1986 Oct; 34(10):728-34. PubMed ID: 2944942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
